Company Tonix Pharmaceuticals Holding Corp Nasdaq
Equities
US8902604094
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 95,543,805 | 84,485,661 ( 88.43 %) | 0 | 88.43 % |
Company contact information
Tonix Pharmaceuticals Holding Corp.
26 Main Street Suite 101
07928, Chatham
+862 799 8599
http://www.tonixpharma.comSector
1st Jan change | Capi. | |
---|---|---|
-2.32% | 92.59B | |
+3.68% | 41.43B | |
-11.72% | 33.49B | |
-20.52% | 14.62B | |
-9.57% | 12.77B | |
-11.34% | 11.58B | |
-43.53% | 11.35B | |
+3.75% | 8.97B | |
-6.32% | 8.3B |